Last $93.57 USD
Change Today +0.77 / 0.83%
Volume 723.2K
VRTX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul S. Anderson Ph.D.

Member of Scientific Advisory Board, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 78 board members in 7 different organizations across 15 different industries.

See Board Relationships
75--

Background*

Dr. Paul S. Anderson, Ph.D., serves as Scientific Advisor at Centrose LLC. Dr. Anderson served as a Vice President of Drug Discovery at Bristol-Myers Squibb Pharmaceuticals Company from 2001 to 2002. He served as Senior Vice President of Chemical and Physical Sciences of the Dupont Pharmaceuticals Company from 1995 to 2001. He has experience in the pharmaceutical industry spans nearly 40 years. He began his career at Merck Sharp and Dohme Research Laboratories where, ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

Former Director
Former Director
Former Director
2002-N/A
Former Director, Chairman of Research & Development Committee and Member of Compensation Committee
2003-2010
Former Independent Director, Member of Corporate Governance & Nominating Committee, Member of Environment, Health & Safety Committee and Member of Special Committee

Education*

Honorary Doctorate
The University of Vermont
Doctorate 1998
The University of Vermont
BS 1959
The University of Vermont
PhD 1963
The University of New Hampshire, Durham

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $93.57 USD +0.77

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Jay T. Flatley Chief Executive Officer and Director
Illumina Inc.
$1.1M
Leonard Bell M.D.Co-Founder, Chief Executive Officer, Treasurer and Director
Alexion Pharmaceuticals, Inc.
$1.2M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.